Valmark Advisers Inc. Has $4.06 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Valmark Advisers Inc. lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,939 shares of the healthcare conglomerate’s stock after selling 31 shares during the period. Valmark Advisers Inc.’s holdings in UnitedHealth Group were worth $4,057,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in UNH. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $27,000. Macroview Investment Management LLC lifted its position in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the period. Delos Wealth Advisors LLC raised its stake in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC acquired a new stake in UnitedHealth Group during the second quarter worth about $31,000. Finally, Global Wealth Strategies & Associates raised its position in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $562.13 on Wednesday. The company has a market cap of $519.08 billion, a price-to-earnings ratio of 36.62, a PEG ratio of 1.66 and a beta of 0.58. The business’s 50 day simple moving average is $582.88 and its 200 day simple moving average is $540.32. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the prior year, the firm earned $6.56 earnings per share. The company’s revenue was up 9.2% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analysts Set New Price Targets

UNH has been the subject of several research analyst reports. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Cantor Fitzgerald raised their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Bank of America dropped their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 24th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.